Cosmetics Direct Says “Validation Failed”: Is It the Data, SPL File, or Account?
Replay one failed cosmetic submission from the visible form through the generated SPL, transmission acknowledgement and FDA processing response before quoting a repair.
Signals to watch
- The request identifies whether the failed submission is a cosmetic facility registration or product listing and names the authorised filer
- The visible validation message, saved SPL version and submission timestamp can be recovered from the same attempt
- The team distinguishes a local authoring error from ESG NextGen transport and FDA processing responses
A screenshot saying “validation failed” does not locate the defect. Recover the submission type, the values visible before submit, the exact saved Structured Product Labeling file, and the first acknowledgement or FDA response. Compare those four artifacts from the same attempt before editing anything. The first artifact that contains the wrong or missing value defines the repair owner.
This is written for a cosmetics regulatory-software solutions consultant reviewing authorised cosmetic-manufacturer, responsible-person, regulatory-operations and software-support Telegram groups. The commercial Signal is a repeatable failed submission with an authorised filer and recoverable file. Seeing it a day late can leave a registration or listing owner retrying against a filing date while each retry overwrites the evidence needed to reproduce the defect.
The following is an illustrative industry case. It is a composite scenario, not a customer story or record of commercial results.
“Cosmetics Direct keeps failing validation. Product listing copied from last year. We fixed the brand name but same red banner—can someone repair the SPL?”
The fragment does not identify the submission type, product, responsible person, facility, account, field, validation message, saved file, prior record, submission route or FDA response.
08:40 — Preserve the failed attempt before another edit
Start a case folder for one attempt. Save a screenshot that includes the full message and field context, export or save the Structured Product Labeling (SPL) file if the route permits it, record the application and version, and preserve the submission timestamp and identifier. SPL is an XML-based Health Level Seven standard used by FDA for structured product and facility information.
Do not accept final.xml as identity. Calculate a file hash or store an immutable copy so the validation output can be tied to the exact file. If the user fixes a brand name and presses submit again, the original red banner and the new file are two different attempts.
FDA published an updated SPL Implementation Guide with Validation Procedures on 14 December 2023. The guide includes cosmetic product facility registrations and product listings within the SPL framework. That dated guide and the current submission instructions—not a copied file from another product—are the rule set to identify first.
09:05 — Decide which submission object failed
Cosmetic facility registration and cosmetic product listing are different objects with different responsible records. FDA’s registration and listing page assigns facility registration to the facility owner or operator and product listing to the responsible person whose name appears on the label under the applicable law.
Record the intended action as one of these: initial registration or listing, update, renewal where applicable, discontinuation, relisting or another supported submission. Then identify the legal entity and record identifier being changed. Copying last year’s product listing into a facility action can produce values that look familiar but belong to the wrong object.
The MoCRA facility-renewal scope article explains how an initial registration date and FDA Establishment Identifier define a renewal task. This article begins later: after a known submission object has failed validation.
09:30 — Separate form validation from SPL validation
FDA describes Cosmetics Direct as an SPL authoring tool. Its forms perform initial validations, create and save the SPL and submit it to FDA for internal processing without requiring the Electronic Submissions Gateway.
That creates two evidence layers before FDA processing:
- Form layer: required value, format, relationship or controlled choice shown in Cosmetics Direct.
- Generated SPL layer: document structure, identifiers, codes and relationships represented in the saved file.
A banner beside a form field points first to the displayed data and form rules. A validation report naming an SPL path, identifier or terminology value points to the generated document and the source mapping behind it. The consultant should compare the visible field value with the corresponding value in the saved SPL; do not infer that they are identical.
10:10 — If another authoring tool was used, inspect the transmission route
Cosmetics Direct is not the only authoring route. FDA also supports other SPL tools, including SPL Xforms, and electronic submission through the Electronic Submissions Gateway Next Generation (ESG NextGen) where applicable.
For an ESG route, preserve the sender account, centre and submission type, file hash, send timestamp, transmission acknowledgement and later processing message. An authentication or transport failure before FDA receives the document is not an SPL business-rule rejection. Conversely, a successful transport acknowledgement does not prove that FDA accepted the document’s content.
Do not tell a Cosmetics Direct user to “fix ESG” unless the failed attempt actually used ESG. FDA states that Cosmetics Direct can submit without it. The EUDAMED data-handoff article illustrates the same diagnostic discipline in a different regulator: actor, device and certificate objects cannot be repaired interchangeably.
11:00 — Replay the first failing rule with one change
Create a four-row replay card:
| Artifact | Evidence from the failed attempt | Owner |
|---|---|---|
| Submission object | Facility or product action and legal record | Regulatory filer |
| Visible input | Field, value and full validation text | Source-data owner |
| Saved SPL | File hash, path or identifier and rule result | Authoring-tool owner |
| Acknowledgement/response | Transport and FDA processing messages | Account, gateway or FDA route owner |
Correct only the first evidenced defect and produce a new saved version. If the visible field changes but the SPL retains the old value, the authoring or mapping layer owns the break. If the file changes and passes local rules but never receives a transport acknowledgement, inspect the account or gateway. If FDA receives it and returns a content response, preserve that response and route it to the regulatory filer and software owner together.
One accepted retry resolves that specific failure. It does not prove that the facility is exempt, the product listing is complete, or FDA has approved the cosmetic. FDA states that registration and listing are not an approval programme.
11:45 — Quote the failed layer, not “SPL repair” in general
Return to the composite fragment. It becomes quote-ready only when the consultant can write:
[Submission action]for[record identifier]failed at[form / generated SPL / transport / FDA response]on[timestamp]. Attempt[file hash or submission ID]shows[exact message]. The first repair owner is[role]; regulatory acceptance remains unknown.
The work may be a source-data correction, one authoring rule, a mapping defect, account recovery, transmission investigation or regulatory-scope review. Those are different deliverables and should not share one flat estimate.
TOP Prospect can join an initial “validation failed” fragment with a later file-version or acknowledgement fragment from Telegram groups the user intentionally connects, preserve their sources and rank the candidate for the solutions consultant. It cannot access Cosmetics Direct or ESG NextGen, inspect a private SPL, submit to FDA, contact the author, decide regulatory scope or promise acceptance. The product discovery boundary ends before the filing system.
The successful handoff is a reproducible failed attempt with one first owner—not another screenshot with a different filename.
FAQ
What does Cosmetics Direct do with SPL?
FDA says it provides data-entry forms, performs initial validations, creates and saves the SPL and submits it for internal FDA processing without requiring ESG.
Does “validation failed” always mean malformed XML?
No. It may identify source data, a form relationship, an SPL rule, an unsupported action or a later FDA processing response.
Is an ESG account problem a Cosmetics Direct problem?
Not automatically. Cosmetics Direct submits without ESG. Other authoring routes may use ESG NextGen, so the actual route and acknowledgement must be recovered.
Can a software vendor promise FDA acceptance after repair?
No. It can repair the evidenced defect. FDA controls processing, while the authorised filer remains responsible for regulatory scope and data.
Frequently asked questions
What does Cosmetics Direct do with an SPL submission?
FDA describes Cosmetics Direct as an SPL authoring tool with data-entry forms that performs initial validations, creates and saves the SPL and submits it to FDA for internal processing without requiring ESG.
Does a Cosmetics Direct validation error always mean the XML file is malformed?
No. The first failure may be a missing or inconsistent form value, an SPL structure or terminology rule, the wrong submission type or a later FDA processing response.
Is an ESG NextGen account problem a Cosmetics Direct problem?
Not necessarily. Cosmetics Direct submits without ESG, while other SPL authoring routes can transmit through ESG NextGen. The route and acknowledgement must be identified first.
Can a software vendor promise FDA acceptance after correcting the error?
No. It can repair evidenced data, authoring or transmission defects. FDA controls validation and processing, and regulatory scope remains the filer’s responsibility.
Sources and further reading
How a Signal worth attention is found
See how Top Prospect finds and organizes Signals worth checking, keeps the original Telegram context, removes duplicates, and helps you decide what to review first. You decide whether to follow up and what to do next.
